| Heart Failure (HF) |
1 |
0.98 |
| Echocardiography |
0 |
0.49 |
| Hypertension |
0 |
0.47 |
| Left Ventricular Dysfunction |
0 |
0.41 |
| Cardiovascular Imaging |
0 |
0.39 |
| Myocardial Infarction (MI) |
0 |
0.37 |
| Primary Care |
0 |
0.37 |
| B-Type Natriuretic Peptide |
0 |
0.33 |
| Type 2 Diabetes Mellitus |
0 |
0.3 |
| Heart |
0 |
0.28 |
| Coronary Artery Disease (CAD) |
0 |
0.26 |
| Biomarker |
0 |
0.24 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.24 |
| Patient Centered Medical Home (PCMH) |
0 |
0.21 |
| Interprofessional Continuing Education |
0 |
0.2 |
| Tobacco Use |
0 |
0.2 |
| Tobacco Cessation |
0 |
0.19 |
| Clinical Guidelines |
0 |
0.16 |
| Cardiovascular Risk Management |
0 |
0.14 |
| Pain Management |
0 |
0.13 |
| Preventive Screening |
0 |
0.12 |
| Antihypertensive Agents |
0 |
0.08 |
| Chronic Disease |
0 |
0.08 |
| Statins |
0 |
0.08 |
| Adherence |
0 |
0.04 |
| Anticoagulation Therapy |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Cardiovascular disease |
0 |
0.04 |
| Continuity of Care |
0 |
0.04 |
| Diabetes Mellitus |
0 |
0.04 |
| Ejection Fraction |
0 |
0.04 |
| Electronic Medical Record |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Hand |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Lipids Management |
0 |
0.04 |
| Medicare |
0 |
0.04 |
| Nurse Practitioners |
0 |
0.04 |
| Outpatient Clinic |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Renin-Angiotensin System |
0 |
0.04 |
| Residency |
0 |
0.04 |
| Statistics |
0 |
0.04 |
| Transplant Evaluation |
0 |
0.04 |
| Wisconsin |
0 |
0.04 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.02 |
| COVID-19 |
0 |
0.02 |
| Electronic Health Record (EHR) |
0 |
0.02 |
| Health Care Reform |
0 |
0.02 |
| Obesity |
0 |
0.02 |
| Palliative Care |
0 |
0.02 |